Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
A randomized controlled add-on trial of fluoxetine and cognitive behavioral therapy for help-seeking men with a sexual interest in children: presentation of the PARACHUTES trial protocol and initial feasibility data
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Psykiatri. ANOVA, Karolinska University Hospital, Stockholm, Sweden.
ANOVA, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
ANOVA, Karolinska University Hospital, Stockholm, Sweden; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Visa övriga samt affilieringar
2024 (Engelska)Ingår i: Frontiers in Psychiatry, E-ISSN 1664-0640, Vol. 15, artikel-id 1448196Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Sexual Interest in Children (SIC) is a major risk factor for sexual offending, yet clinical trials are sparse. The present protocol outlines a randomized controlled trial (RCT) that aims to investigate the effectiveness of fluoxetine and Cognitive Behavioral Therapy (CBT) in help-seeking men with SIC.

Methods: Adult men contacting the Swedish telephone helpline PrevenTell are screened for inclusion and invited to further assessment on site. One hundred and eleven men with SIC (defined as DSM-5 pedophilic disorder or hebephilia) will be randomized (1:1:1 ratio) to receive one of three interventions for 14 weeks: (1) an internet-administered psychoeducational program (iPP), (2) iPP and the addition of fluoxetine 20-40 mg or (3) iPP and the addition of internet-administered CBT (iCBT). Exclusion criteria include severe psychiatric illness, contraindicating treatment and an elevated risk of committing hands-on sexual offences. Symptom intensity is assessed at baseline, pre-treatment, every other week for 12 weeks, and post treatment. The primary outcome measure is the Sexual Interest in Children: Current Assessment Scale (SIC: CAS) that quantifies sexual behaviors associated with SIC as well as perceived distress and impairment. Secondary outcomes include measures of dynamic risk-factors for committing sexual offences.

Results: The data collected during the initial 20 months of recruitment were analyzed to predict the required number of individuals to be screened and estimate the probable length of the data collection phase. As of March 2022 to November 2023, 146 men have called PrevenTell and disclosed a sexual interest in minors. Following pre-screening, 110 men were excluded from participation in the trial. Current SSRI therapy was the primary reason for exclusion (n = 24; 22%), followed by an elevated risk of committing hands-on sexual offences (n = 14; 13%). Among the 31 men who underwent the screening procedure on site, 26 were allocated to either iPP, iPP+fluoxetine, or iPP+iCBT. The recruitment rate indicates that the trial will be concluded within the pre-estimated timeframe.

Discussion: This is the first RCT of treatment with SSRI and iCBT in a population of help-seeking men with SIC. The significance of this trial and its methodological strengths and limitations are discussed.

Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2024. Vol. 15, artikel-id 1448196
Nyckelord [en]
child sexual abuse, cognitive behavioral, fluoxetine, paraphilic disorder, pedophilic disorder, preventive psychiatry, therapy
Nationell ämneskategori
Psykiatri
Identifikatorer
URN: urn:nbn:se:umu:diva-229422DOI: 10.3389/fpsyt.2024.1448196ISI: 001296543100001PubMedID: 39184448Scopus ID: 2-s2.0-85201819609OAI: oai:DiVA.org:umu-229422DiVA, id: diva2:1895979
Forskningsfinansiär
Vetenskapsrådet, 2023-0191Tillgänglig från: 2024-09-09 Skapad: 2024-09-09 Senast uppdaterad: 2024-09-10Bibliografiskt granskad

Open Access i DiVA

fulltext(1965 kB)56 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1965 kBChecksumma SHA-512
9f9b2c711b084b417b3829e9e52f32a8fb9e54f511c1474216ef1a82dcf7d2afd0120817b0d37277a3345db485a2f3bfee217e6a66d8c582bbb86b770118df6c
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Adebahr, RoberthBoström, AdrianJokinen, JussiSavard, Josephine

Sök vidare i DiVA

Av författaren/redaktören
Adebahr, RoberthBoström, AdrianJokinen, JussiSavard, Josephine
Av organisationen
Psykiatri
I samma tidskrift
Frontiers in Psychiatry
Psykiatri

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 56 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 354 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf